H1 Company Research Report

Company Overview

• Name: H1

• Mission: To create a healthier future worldwide by unlocking and democratizing global access to critical healthcare expertise, healthcare provider information, claims data, groundbreaking research, and connected insights.

• Founded: 2017

• Founders: Ariel Katz (Co-Founder & CEO), Ian Sax (Co-Founder & President)

• Key People:

• Ariel Katz, Co-Founder & CEO

• Ian Sax, Co-Founder & President

• Devin Basinger, SVP of People Operations

• Deb Schwartz, Chief Financial Officer

• Headquarters: New York, NY, USA

• Number of Employees: More than 300

• Revenue: No information is available

• Known For: As a leading source of truth for global healthcare professional, clinical, and research information, H1 connects life sciences, healthcare professionals, and non-governmental organizations with the right data and insights.

Products

HCP Universe

• Description: A platform providing extensive access to healthcare provider information.

• Key Features: Comprehensive database on healthcare professionals.

Trial Landscape

• Description: A clinical trial management system aimed at accelerating time to market through access to diverse principal investigator pools, site performance data, and patient diversity insights.

• Key Features: Patient demographic insights, site performance analytics, diversity data integration.

Precise

• Description: No information is available

• Key Features: No information is available

H1 Connect

• Description: A platform facilitating connections between healthcare professionals and NGOs to support global medical missions and humanitarian efforts.

• Key Features: Links doctors globally, supports volunteer work and emergency responses.

Recent Developments

• Partnerships: H1 has partnered with CTI to streamline clinical trial PI and site selection, enhance diversity efforts, and increase operational efficiency. The partnership focuses on adhering to FDA diversity guidelines by using H1's Trial Landscape platform to develop inclusive clinical trials.

• New Products/Features: No new products were explicitly listed, but H1 Connect has been used effectively as a tool to bridge healthcare professionals with NGOs in humanitarian missions, such as trauma surgery training in Ukraine with Global Response Medicine.

• Recognition and Awards: H1 was honored with a spot on the New York Digital Health 100 for the third consecutive year and was recognized as one of Forbes' Best Startup Employers in 2024.

• Personnel Additions: H1 appointed Karen Walker, a seasoned marketing and technology executive, to its Board of Directors in May 2024.

Additional Strategic Initiatives

• Diversity & Equity: H1 has expanded the Trial Landscape platform with U.K. diversity data to enhance clinical trial equity and meet evolving regulatory standards.

• AI and Technology Integration: The Trial Landscape platform now incorporates GenosAI™, enabling faster clinical trial execution by querying robust databases for trial insights instantly.

In summary, H1 continues to establish itself as a pivotal player in healthcare data management and access, leveraging strategic partnerships and AI capabilities to enhance clinical trial efficiencies and foster global healthcare collaborations.